Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
+12.76%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$50.5B
AUM Growth
+$3.68B
(+7.8%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-2.57%
Top 10 Holdings %
Top 10 Hldgs %
27.58%
Holding
1,779
New
23
Increased
1,010
Reduced
375
Closed
40
Top Buys
| 1 |
Estee Lauder
EL
|
$151M |
| 2 |
Crown Castle
CCI
|
$149M |
| 3 |
Advanced Micro Devices
AMD
|
$147M |
| 4 |
Thermo Fisher Scientific
TMO
|
$124M |
| 5 |
Charles Schwab
SCHW
|
$117M |
Top Sells
| 1 |
Walmart
WMT
|
$213M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$208M |
| 3 |
UnitedHealth
UNH
|
$181M |
| 4 |
Apple
AAPL
|
$139M |
| 5 |
AstraZeneca
AZN
|
$126M |
Sector Composition
| 1 | Technology | 27.28% |
| 2 | Healthcare | 15.74% |
| 3 | Financials | 12.65% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Dorman Products
DORM
$5B
| $24.6M | 0.05% |
295,442
-8,890
| -3% | -$742K |
|
277
Booking.com
BKNG
$178B
| $24.1M | 0.05% |
6,787
-12,923
| -66% | -$45.8M |
|
278
MSCI
MSCI
$42.9B
| $24.1M | 0.05% |
42,537
+27,949
| +192% | +$15.8M |
|
279
Lithia Motors
LAD
$8.74B
| $23.9M | 0.05% |
72,705
+15,655
| +27% | +$5.15M |
|
280
Schlumberger
SLB
$53.4B
| $23.8M | 0.05% |
457,920
+98,037
| +27% | +$5.1M |
|
281
Twilio
TWLO
$16.7B
| $22.8M | 0.05% |
300,881
+159,325
| +113% | +$12.1M |
|
282
Vaxcyte
PCVX
$4.29B
| $22.7M | 0.04% |
361,131
+85,345
| +31% | +$5.36M |
|
283
Diamondback Energy
FANG
$40.2B
| $22.7M | 0.04% |
146,069
+15,073
| +12% | +$2.34M |
|
284
W.W. Grainger
GWW
$47.5B
| $22.6M | 0.04% |
27,234
+1,692
| +7% | +$1.4M |
|
285
NiSource
NI
$19B
| $22.5M | 0.04% |
847,172
-190,368
| -18% | -$5.05M |
|
286
Bunge Global
BG
$16.9B
| $22.2M | 0.04% |
220,073
+62,169
| +39% | +$6.28M |
|
287
Casella Waste Systems
CWST
$6.01B
| $22M | 0.04% |
256,884
-32,863
| -11% | -$2.81M |
|
288
Biogen
BIIB
$20.6B
| $21.9M | 0.04% |
84,463
-130,009
| -61% | -$33.6M |
|
289
Builders FirstSource
BLDR
$16.5B
| $21.5M | 0.04% |
128,875
-6,418
| -5% | -$1.07M |
|
290
Nucor
NUE
$33.8B
| $21M | 0.04% |
120,874
+673
| +0.6% | +$117K |
|
291
Kimberly-Clark
KMB
$43.1B
| $21M | 0.04% |
172,548
-7,989
| -4% | -$971K |
|
292
Phathom Pharmaceuticals
PHAT
$875M
| $20.8M | 0.04% |
2,280,000
+547,828
| +32% | +$5M |
|
|
BPMC
293
DELISTED
Blueprint Medicines
BPMC
| $20.8M | 0.04% |
225,124
+196,984
| +700% | +$18.2M |
|
294
Okta
OKTA
$16.1B
| $20.6M | 0.04% |
227,603
+32,348
| +17% | +$2.93M |
|
295
CSX Corp
CSX
$60.6B
| $20.4M | 0.04% |
587,045
+66,957
| +13% | +$2.32M |
|
296
Freeport-McMoran
FCX
$66.5B
| $20.3M | 0.04% |
475,764
-217,824
| -31% | -$9.27M |
|
|
ANSS
297
DELISTED
Ansys
ANSS
| $20.1M | 0.04% |
55,329
+5,615
| +11% | +$2.04M |
|
298
US Physical Therapy
USPH
$1.3B
| $20M | 0.04% |
214,972
-91,182
| -30% | -$8.49M |
|
299
Edwards Lifesciences
EW
$47.5B
| $19.9M | 0.04% |
261,527
+29,234
| +13% | +$2.23M |
|
300
FIVE9
FIVN
$2.06B
| $19.3M | 0.04% |
245,350
+142,669
| +139% | +$11.2M |
|